Moreover, in a randomized, double-blind placebo-controlled trial recruiting 67 NAFLD patients, intervention with green tea tablets (550 mg/time, once daily, 12 weeks) could also ameliorate some indices such as BMI, AST, and FBG, though not change body weight, ALT, HOMA-IR, ferritin, or total iron binding capacity [149]. This evidence concerns the gene GPT and metabolic dysfunction-associated steatotic liver disease.